In addition, the indications of tirpotide under development include plaque psoriasis (PSO), non-alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) and morbidity and mortality in obese patients (MMO), etc., and more than 140 clinical studies have been conducted
No direct retatrutide-versus-tirzepatide randomised controlled trial has been published or announced as of April 2026
The full analysis and other data on health costs are available in the Peterson-KFF Health System Tracker, an online information hub dedicated to monitoring and assessing the performance of the U.S
Retatrutide for managing overweight and obesity [GID-TA11845]
It is provided for educational purposes and is not intended to replace individualized medical advice or clinical decision-making.
Whether you decide on prescription weight loss medication or not, a foundational weight loss plan with a personal dietitian who specializes in weight loss and glucose monitoring will help you see more success